Charles River Laboratories | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Agilent USD 899M 18M 2025-01
Align Technology USD 696.94M 15.17M 2024-12
Bio-Rad Laboratories USD 355.1M 803K 2024-12
Bruker USD 493.3M 74.5M 2024-12
Cardinal Health USD 1.94B 39M 2024-12
Charles River Laboratories USD 319.68M 48.09M 2024-12
Cigna USD 6.46B 140M 2024-12
CVS Health USD 12.9B 341M 2024-12
Danaher USD 3.89B 489M 2024-12
Dentsply International USD 455M 40M 2024-12
Elevance Health 11.94B 215M 2024-12
Galapagos EUR -37430000 97.26M 2024-12
Hologic USD 580.5M 22.8M 2024-12
Humana 3.83B 3.35B 2024-12
Illumina USD 728M 17M 2024-12
Incyte USD 1.1B 38.34M 2024-12
IQVIA Holdings USD 1.38B 0 2024-12
Laboratory Of America USD 896.3M 8.1M 2024-12
Lonza CHF 1.12B 276M 2024-06
McKesson USD 3.25B 5M 2024-12
Merck EUR 3.14B 89M 2024-09
Mettler Toledo International USD 639.31M 66.85M 2024-12
Novartis USD 10.23B 294M 2024-12
Pfizer USD 12.11B 718M 2024-12
Quest Diagnostics USD 858M 42M 2024-12
Revvity USD 412.29M 27.47M 2024-12
Thermo Fisher Scientific USD 4.82B 494M 2024-12
United Therapeutics USD 660M 5.8M 2024-12
UnitedHealth 21.31B 1.72B 2024-12
Walgreens Boots Alliance USD 6.78B 526M 2024-11
Waters USD 524.2M 85.55M 2024-12
West Pharmaceutical Services USD 273.6M 8.9M 2024-12



Charles River Laboratories Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.